Tosi Michael F
Department of Pediatrics, Mount Sinai School of Medicine, New York, NY, USA.
J Allergy Clin Immunol. 2005 Aug;116(2):241-9; quiz 250. doi: 10.1016/j.jaci.2005.05.036.
The human host survives many infectious challenges in the absence of preexisting specific (adaptive) immunity because of the existence of a separate set of protective mechanisms that do not depend on specific antigenic recognition. These antigen-independent mechanisms constitute innate immunity. Antimicrobial peptides are released at epithelial surfaces and disrupt the membranes of many microbial pathogens. Toll-like receptors on epithelial cells and leukocytes recognize a range of microbial molecular patterns and generate intracellular signals for activation of a range of host responses. Cytokines released from leukocytes and other cells exhibit a vast array of regulatory functions in both adaptive and innate immunity. Chemokines released from infected tissues recruit diverse populations of leukocytes that express distinct chemokine receptors. Natural killer cells recognize and bind virus-infected host cells and tumor cells and induce their apoptosis. Complement, through the alternative and mannose-binding lectin pathways, mediates antibody-independent opsonization, phagocyte recruitment, and microbial lysis. Phagocytes migrate from the microcirculation into infected tissue and ingest and kill invading microbes. These innate immune mechanisms and their interactions in defense against infection provide the host with the time needed to mobilize the more slowly developing mechanisms of adaptive immunity, which might protect against subsequent challenges.
由于存在一套独立的不依赖于特异性抗原识别的保护机制,人类宿主在缺乏预先存在的特异性(适应性)免疫的情况下能够抵御许多感染性挑战。这些不依赖抗原的机制构成了固有免疫。抗菌肽在上皮表面释放,破坏许多微生物病原体的膜。上皮细胞和白细胞上的Toll样受体识别一系列微生物分子模式,并产生细胞内信号以激活一系列宿主反应。白细胞和其他细胞释放的细胞因子在适应性免疫和固有免疫中都发挥着广泛的调节功能。感染组织释放的趋化因子招募表达不同趋化因子受体的多种白细胞群体。自然杀伤细胞识别并结合病毒感染的宿主细胞和肿瘤细胞,并诱导其凋亡。补体通过替代途径和甘露糖结合凝集素途径,介导不依赖抗体的调理作用、吞噬细胞募集和微生物裂解。吞噬细胞从微循环迁移到感染组织,摄取并杀死入侵的微生物。这些固有免疫机制及其在抗感染中的相互作用为宿主提供了动员发展较慢的适应性免疫机制所需的时间,适应性免疫机制可能抵御后续挑战。